No abstract available
MeSH terms
-
Acute Disease
-
Animals
-
Apoptosis / drug effects
-
Atherosclerosis / complications
-
Atherosclerosis / drug therapy*
-
Atherosclerosis / enzymology
-
Atherosclerosis / pathology
-
Cardiovascular Diseases / enzymology
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / pathology
-
Cardiovascular Diseases / prevention & control*
-
Enzyme Inhibitors / pharmacology*
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Inflammation Mediators / metabolism
-
Mice
-
Necrosis
-
Oxidative Stress / drug effects
-
Poly (ADP-Ribose) Polymerase-1
-
Poly(ADP-ribose) Polymerase Inhibitors*
-
Poly(ADP-ribose) Polymerases / metabolism
-
Rupture
Substances
-
Enzyme Inhibitors
-
Inflammation Mediators
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Parp1 protein, mouse
-
Poly (ADP-Ribose) Polymerase-1
-
Poly(ADP-ribose) Polymerases